This legislation aims to streamline the handling of petitions that are primarily intended to delay the approval of drug applications, ensuring that such petitions do not obstruct the timely availability of affordable medicines. It clarifies the criteria under which these petitions can be denied, promoting efficiency in the drug approval process. Key provisions include a clearer definition of what constitutes a delay-inducing petition, allowing the Secretary of Health and Human Services to deny these petitions at any time if they lack valid scientific or regulatory grounds.